Cuban interferon proven effective against COVID-19
Data shows that only 5.5% of patients treated with Heberon developed serious complications

Orfilio Peláezmay 12, 2020 09:05:54

Currently more than 80 countries have expressed interest in acquiring Heberon.Photo: CIGB

Since the appearance, March 11, of the first cases of COVID-19 in Cuba, the country’s Ministry of Public Health (Minsap) has reported that the inclusion of Recombinant Human Interferon Alpha 2b in treatment protocols for these patients has shown positive results.

Details on the effectiveness of the product were presented by Dr. Eulogio Pimentel Vázquez, director of the Center for Genetic Engineering and Biotechnology (CIGB), affiliated with the BioCubaFarma Enterprise Group, where the medication was first produced in the late 1980s. Continue reading Cuban interferon proven effective against COVID-19 →